The University of Chicago Header Logo

Connection

Rohan Katipally to Paclitaxel

Back to Details
This is a "connection" page, showing publications Rohan Katipally has written about Paclitaxel.
Rohan Katipally
Connection Strength
0.049
Paclitaxel
  1. Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.